Can a daily supplement boost your Cells' energy? new study seeks answers
NCT ID NCT07428889
First seen Jun 25, 2026 · Last updated Aug 07, 2026 · Updated 3 times
Summary
This pilot trial is testing whether a proprietary nutritional supplement can increase levels of NAD+, a molecule important for cellular energy and aging, in healthy adults aged 45 to 65. Participants will take either the supplement or a placebo daily for 60 days. The study aims to measure changes in NAD+ and related markers, as well as subjective feelings of cognitive function.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- proprietary nutritional supplement containing nicotinamide metabolites and plant extracts
- What this could lead to
- If it works, this could point toward a supplement that supports cellular energy and healthy aging in adults.
- What could go wrong
- This is a very small, early pilot study in healthy people, so results may not apply to the general population or lead to any proven health benefit.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
29 people
The number who actually took part.
- Started
-
Feb 2026
- Finished
-
Apr 2026
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
45 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Males and females, ≥45 to ≤65 years of age 2. BMI ≥18.5 and \<30.0 kg/m2 3. Ambulatory and currently free of injury or other physical impairment that hinders mobility. 4. Willing to use personal smart phone with operating system (Android version 12.0 or newer; iOS version 16 or newer). 5. Willingness to maintain current skin care regimen and avoid any skin-related medical procedures. 6. Willing to adhere to all study procedures, including lifestyle considerations and sign forms providing informed consent to participate in the study and authorization to release relevant protected health information to the Clinical Investigator. Exclusion Criteria: 1. Is currently following, or planning to be on, a weight loss regimen. 2. Weight loss or gain \>4.5 kg. 3. History of gastrointestinal surgery for weight reducing purposes. 4. History of an eating disorder (e.g., anorexia nervosa or bulimia nervosa, binge eating) at the discretion of the Clinical Investigator. 5. History of neurologic disorder that could produce cognitive deterioration. 6. History of bouts of delirium, confusion, repeated minor head injury or a single injury. 7. History of unconventional sleep patterns or a diagnosed sleep disorder. 8. History of any infective or inflammatory brain disease. 9. Use of tobacco/nicotine products. 10. Use of hemp/marijuana products. 11. Unstable use of any prescription medication. 12. Unstable use (initiation or change in dose) of hormonal contraceptives or therapy. 13. Use of any dietary supplements (orally or infused), other than a conventional once daily multi-vitamin. 14. Use of medication(s) or dietary supplement(s) known to affect absorption. 15. Recent history of or strong potential for alcohol or substance abuse. 16. Exposed to any non-registered drug product. 17. A score of \<7 on the Vein Access Scale Assessment. 18. History or presence, on the basis of the medical history or screening labs, of clinically important cardiac, renal, hepatic, endocrine (including diabetes mellitus), pulmonary, gastrointestinal, biliary, pancreatic, or neurological disorders. 19. Uncontrolled hypertension. 20. Known allergy to any ingredients contained in the study product. 21. Any signs or symptoms of active infection of clinical relevance. 22. History or presence of cancer in the prior 2 years, except for non-melanoma skin cancer. 23. History of any major trauma or major surgical event. 24. Female who is pregnant, planning to be pregnant during the study period, lactating, or is of childbearing potential with unstable use of sex hormones for contraception. 25. An employee or representative who has a financial interest in Sponsor organization.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Healthy adult are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Biofortis Clinical Research
Addison, Illinois, 60101, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can magnetic brain zaps ease the pain of a sleepless body?
- Can poor sleep make you hurt more? study probes Insomnia's link to pain
- Does soreness after exercise disrupt sleep more for people with insomnia?
- Could a fatty meal skew your eye scan?
- Can a week at sea level reset lung pressure for high-altitude dwellers?
- Can a week at sea level ease the strain of High-Altitude living on the lungs?